Sysmex (OTCMKTS:SSMXY) Shares Gap Down – Should You Sell?

by · The Cerbat Gem

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $9.87, but opened at $9.41. Sysmex shares last traded at $9.76, with a volume of 113,453 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group raised Sysmex from a “hold” rating to a “buy” rating in a research note on Thursday, October 9th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy”.

Get Our Latest Research Report on Sysmex

Sysmex Price Performance

The company has a fifty day simple moving average of $10.58 and a 200 day simple moving average of $13.40. The stock has a market capitalization of $6.14 billion, a price-to-earnings ratio of 19.52 and a beta of 1.17. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.49 and a current ratio of 3.34.

Sysmex (OTCMKTS:SSMXY – Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. Sysmex had a return on equity of 9.86% and a net margin of 9.32%.The company had revenue of $826.60 million during the quarter, compared to the consensus estimate of $880.80 million. Equities research analysts forecast that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

About Sysmex

(Get Free Report)

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

Featured Articles